IFN-Induced Protein with Tetratricopeptide Repeats 2 Limits Autoimmune Inflammation by Regulating Myeloid Cell Activation and Metabolic Activity
- 15 March 2023
- journal article
- research article
- Published by Oxford University Press (OUP) in The Journal of Immunology
- Vol. 210 (6) , 721-731
Abstract
Besides antiviral functions, type I IFN expresses potent anti-inflammatory properties and is being widely used to treat certain autoimmune conditions, such as multiple sclerosis. In a murine model of multiple sclerosis, experimental autoimmune encephalomyelitis, administration of IFN-β effectively attenuates the disease development. However, the precise mechanisms underlying IFN-β–mediated treatment remain elusive. In this study, we report that IFN-induced protein with tetratricopeptide repeats 2 (Ifit2), a type I and type III IFN-stimulated gene, plays a previously unrecognized immune-regulatory role during autoimmune neuroinflammation. Mice deficient in Ifit2 displayed greater susceptibility to experimental autoimmune encephalomyelitis and escalated immune cell infiltration in the CNS. Ifit2 deficiency was also associated with microglial activation and increased myeloid cell infiltration. We also observed that myelin debris clearance and the subsequent remyelination were substantially impaired in Ifit2−/− CNS tissues. Clearing myelin debris is an important function of the reparative-type myeloid cell subset to promote remyelination. Indeed, we observed that bone marrow–derived macrophages, CNS-infiltrating myeloid cells, and microglia from Ifit2−/− mice express cytokine and metabolic genes associated with proinflammatory-type myeloid cell subsets. Taken together, our findings uncover a novel regulatory function of Ifit2 in autoimmune inflammation in part by modulating myeloid cell function and metabolic activity.Keywords
All Related Versions
Funding Information
- HHS | National Institutes of Health (AI125247)
- HHS | National Institutes of Health (NS123532)
- HHS | National Institutes of Health (CA068782)
This publication has 65 references indexed in Scilit:
- Targeting the Shift from M1 to M2 Macrophages in Experimental Autoimmune Encephalomyelitis Mice Treated with FasudilPLOS ONE, 2013
- Interferon-β Therapy Against EAE Is Effective Only When Development of the Disease Depends on the NLRP3 InflammasomeScience Signaling, 2012
- Hexokinase 2 is a key mediator of aerobic glycolysis and promotes tumor growth in human glioblastoma multiformeJournal of Experimental Medicine, 2011
- Molecular dissection of reactive astrogliosis and glial scar formationTrends in Neurosciences, 2009
- CCR2+Ly-6Chi monocytes are crucial for the effector phase of autoimmunity in the central nervous systemBrain, 2009
- Identification of Human S100A9 as a Novel Target for Treatment of Autoimmune Disease via Binding to Quinoline-3-CarboxamidesPLOS Biology, 2009
- Engagement of the Type I Interferon Receptor on Dendritic Cells Inhibits T Helper 17 Cell Development: Role of Intracellular OsteopontinImmunity, 2008
- The type I IFN induction pathway constrains Th17-mediated autoimmune inflammation in miceJournal of Clinical Investigation, 2008
- The transcription factor HIF-1α plays a critical role in the growth factor-dependent regulation of both aerobic and anaerobic glycolysisGenes & Development, 2007
- A guided tour into subcellular colocalization analysis in light microscopyJournal of Microscopy, 2006